Share

Mycopreneur
Alex Dorr: Building & Scaling Mushroom Revival
Alex Dorr is the Founder and CEO of Mushroom Revival, one of the quintessential purveyors of premium quality functional mushroom products the world over. He is also the host of the #1 mushroom podcast in the world, called - wait for it - Mushroom Revival.
And above and beyond all that, Alex is just a solid dude who is obsessed with the power of cordyceps and mushrooms in general.
Alex has all kinds of mushroom juju and creative energies afloat, educating the world about the power and the efficacy of fruiting body tinctures and planting a tree for every single product sold -- more than 45,000 trees to date. Alex has a goal of planting one million trees via Mushroom Revival and their commitment to reforestation.
I can also say Alex has been extremely supportive of the Mycopreneur Podcast and completely earnest in his willingness to support our own little corner of the mushroom universe here, and that means the world to us.
Today we’re going to talk about his entre into the world of mushrooms, we’re talking mycoremediation and it’s vast potential (and also it’s practical limitations), we’re talking the science of cordyceps, we’re talking how he scaled mushroom revival, we’re talking transparency in business culture, a little bit of mushroom history, and a lot more juicy morels of mycopreneial wisdom and demystification.
Please subscribe and leave a review wherever you listen to your podcasts! Hit us up on Instagram or YouTube and let us know who we should tap in with next!
More episodes
View all episodes

Soren Shade: How Drugs Become Illegal
01:05:31|Soren Shade is a drug researcher known for producing Hamilton's Pharmacopeia on Vice and as the Founder of Kratom leaf tea company Top Tree Herbs.We discuss the evolution of drug markets and policy with a long-view approach beginning in the 1870's and on through today's rapidly shifting drug legislation frameworks globally. Please rate and review this episode wherever you're listening ( :
Decentralized Funding for Psychedelic Research with PsyDAO
46:49|PsyDAO is a Decentralized Autonomous Community that is funding decentralized psychedelic science and fast-tracking the careers of emergent researchers by investing in their work across multiple early career fellowship projects. Tyler Quigley and Brittney Scott join me today to discuss the function of a DAO, the work they're funding, and how PsyDAO is decoupling psychedelic science and research from limiting patterns that have defined research in the past.
Erik Lomen: Anarchists in the Mushroom Business
54:16|Erik Lomen is the Founder of Maine Cap N' Stem and the host of MycoWizards podcast. He joins us on Mycopreneur Podcast today to discuss the evolution of the company and the mushroom industry in the United States at large while sharing practical insights and intel on running and scaling an independent mycology outfit with years of experience to their name.
Dillan DiNardo: AI In Psychedelic Drug Development
43:44|Dillan DiNardo, Co-Founder and CEO of Mindstate Design Labs, returns to the Mycopreneur Podcast to share updates on the companies progress as a clinical-stage AI neuroengineering platform and drug development outfit. We explore how Mindstate Design is leveraging artificial intelligence in their drug development process, discuss the origins of the company and it's connection to legendary drug chemist Alexander "Sasha" Shulgin, and cover the evolving landscape of psychedelic drug research and where it could all go from here.Please rate and review wherever you're listening ( :
Lee Carroll: Where Mushroom Tradition Meets Science
45:41||Season 3Lee Carroll is the Lead Medical Herbalist at Real Mushrooms and returns to the Mycopreneur Podcast to share updates on his research and journey deeper into the history of traditional mushroom use as well as the modern science to substantiate functional mushroom claims. We discuss mushrooms for longevity, Reishi for heart health, the connection between primates and mushrooms, ways to prevent cognitive decline, and much more.Please rate and review this episode wherever you're listening ( :
Robert Lattig: Healing Herbals & The Kanna Industry
37:01|Robert Lattig of Healing Herbals returns to the Mycopreneur Podcast to discuss the rise of the Kanna supplement market alongside Amanita muscaria mushrooms, Jamaican Dogwood and much more.
James McConchie: Building Haight Street Shroom Shoppe
51:49|James McConchie is the Founder of Haight Street Shroom Shoppe and started cultivating mushrooms years ago to provide access for his wife as she underwent Chemotherapy - today, he stands as one of the most respected and venerable mushroom entrepreneurs in the San Francisco area and beyond. He joins us today to share lessons from 5 years of running the Haight Street Shroom Shoppe, mushroom culture in California's Bay Area and beyond, and his recent research and development into microdosing for dogs alongside Doc Rob silver of Real MushroomsPlease rate and review this episode wherever you're listening ( :
Joshua White: TripCheck by Fireside Project
34:40|Joshua White of Fireside Project joins us today to share insights about their innovative new "TripCheck" service. TripCheck fills a crucial gap between preparation and real-time crisis support, offering planned wellness check-ins that can prevent challenges from escalating.We also learn about how Josh found his way into building Fireside Project, the culture of psychedelic use in contemporary society, and more.Please rate and review this episode wherever you're listening -
Joe Dolce: Modern Psychedelics
01:02:09||Season 3Author and journalist Joe Dolce joins us today to dive into his new book Modern Psychedelics.This book offers an expansive and high-level view of psychedelics as they exist in today's world, and we dive into a number of rich subjects on the podcast today ranging from the creative impetus facilitated by non-ordinary states of consciousness to drug policy reform initiatives to the cultural milieu of ibogaine in the west. Please rate and review this podcast wherever you're listening.